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Size-exclusion chromatography (SEC) is a useful method for quantification of protein aggregates because 
of its high throughput capacity and highly quantitative performance. One of the problems in this method 
concerns polysorbates, which are well-known additives for protein-containing products to prevent protein 
aggregation, but frequently interfere with the photometric detection of protein aggregates. We developed a 
new SEC method that can separate polysorbates from protein sample solutions in an on-line mode with a 
precolumn with size exclusion and reversed-phase mixed modes. The precolumn can effectively trap 
polysorbates in aqueous mobile phase, and the trapped polysorbates are easily eluted with 
acetonitrile-containing aqueous mobile phase to clean the precolumn. Small parts of protein aggregates 
may be also trapped on the precolumn depending on temperature and proteins. Setting appropriate column 





 Nowadays, protein-based pharmaceutical products have rapidly been advanced. The situation 
increases demands for development of analytical technologies for protein aggregates, which are common 
sources of protein instability and are considered to concern their potential to elicit immune responses [1-5]. 
Various analytical methods that can evaluate protein aggregates have been developed such as analytical 
ultracentrifugation and asymmetric field flow fractionation [6-10]. However, these methods still have 
several weak points, for example, low throughput, need for professional skills, or difficulty in method 
development [10]. In contrast, size-exclusion high performance liquid chromatography (SEC-HPLC) with 
high throughput capacity and highly quantitative performance is frequently used and indispensable for 
quantification of protein aggregates.  
 In SEC-HPLC, proteins and their aggregates are separated based on the difference in the 
permeation property into pores of stationary phase (e.g., silica-based polymeric beads). Larger molecules 
(e.g., aggregates) or non-spherical (e.g., straight chain) molecules in a mixture are rapidly excluded and 
therefore eluted from the resin pores, while smaller molecules with greater access to the pores are eluted 
more slowly [11]. In many marketed biopharmaceuticals, nonionic surfactants such as polysorbate 80 
(PS80) and polysorbate 20 (PS20) are included as stabilizers to protect the active protein against 
denaturation or aggregate formation [12–16]. The molecular mass of the polysorbates is usually lower than 
that of most of proteins and protein aggregates. However, the polysorbates present in some formulations are 
eluted at retention times close to those of protein aggregates and then interfere with aggregate quantitation 
in SEC-HPLC. This interference becomes a serious problem to perfome sensitive and quantitative 
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SEC-HPLC methods capable of quantitating protein aggregates in formulated products. Unfortunately, it is 
very difficult to selectively separate detergents from protein solutions. Some methods are reported to 
separate detergents from protein solutions [17-22], but these methods take time because they cannot be 
connected directly to an analytical column and the recovery of protein is not 100%. Gunturi et al. proposed 
to utilize potassium phosphate buffer containing isopropyl alcohol as a mobile phase in SEC-HPLC [23]. 
They found that the peaks of the polysorbates were completely disappeared when isopropyl alcohol content 
was increased up to 20–25% range in the mobile phase [23]. However, isopropyl alcohol at such high 
concentrations may cause some damage to proteins. Therefore, some separation methods without use of 
organic solvents are strongly desired for long time. In this study, we will propose a new SEC-HPLC 
method that can separate the polysorbates from protein samples in an on-line mode using a precolumn with 
mixed characteristics of size exclusion phase and reversed-phase. We will also show the significance of the 
temperature control in the on-line separation to perform sensitive and quantitative SEC-HPLC methods.  
 
2. Experimental 
2.1. Chemicals and reagents 
 Sodium monobasic phosphate, sodium dibasic phosphate and human serum albumin (HSA, 
lyophilized powder, Fatty acid free, globulin free, ≥ 99%, product # A3782) were from Sigma-Aldrich (St. 
Louis, MO, USA). Sodium chloride (NaCl) was from Wako Pure Chemicals (Tokyo, Japan). Dulbecco’s 
phosphate-buffered saline (PBS) was from Nissui Seiyaku (Tokyo, Japan). Polysorbate 80 (PS80) was from 
NOF Corp. (Tokyo, Japan), while polysorbate 20 (PS20) was from Croda (East Yorkshire, England). 
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Synagis injection containing Palivizumab was purchased from Abbvie (IL, USA). The pure standard 
sample of recombinant human erythropoietin (r-HuEPO) was obtained from Kyowa Hakko Kirin (Tokyo, 
Japan). 
 
2.2. Sample preparations 
HSA and synagis injection were reconstituted by addition given amount of water and dialyzed 
with PBS for 24 h. The HSA was diluted with the PBS to 3 mg/mL, and the synagis injection was diluted 
with the PBS to 1 mg/mL. The commercially available r-HuEPO was also dialyzed with the PBS and 
diluted with the PBS to 1 mg/mL. Heat-induced r-HuEPO aggregate-containing samples were prepared by 
heating the diluted r-HuEPO sample for one day at 40 C. PS80 and PS20 were diluted with the PBS to 
0.01, 0.02, 0.05, 0.1, 0.2, 0.5 and 1 mg/mL. All the samples were stored at 2-8 C until the HPLC 
characterization described in Section 2.3. 
 
2.3. SEC-HPLC methods 
 SEC-HPLC was performed with an Agilent 1100 chromatography system connected to a Tosoh 
TSKgel G3000SWXL (300  7.8 mm, 5 μm particle size). The chromatographic control, data acquisition 
and data analysis were performed using Chemstation (Agilent Technologies). The samples were set on an 
auto-sampler (as an accessory of the Agilent 1200 chromatography system) at 4 C in a refrigerator. The 
UV detector was operated at a wavelength of 215 nm. The mobile phase for the SEC-HPLC method was 
the PBS. The mobile phase was filtered with a 0.45-μm Millipore filter and was degassed with an online 
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degasser. The flow rate was 0.5 mL/min and the column was maintained at 25 C unless otherwise noted. In 
order to prevent automatic stopping (due to condensation detection at lower temperatures), the leak sensor 
of the column oven was turned off. The method run time was set to 40 min.  
   A Shodex MSpak GF-4A (10  4.6 mm, 9 μm particle size) was used as a precolumn to separate the 
polysorbates. The column, when necessary, was connected to the front of the main column (Tosoh TSKgel 
G3000SWXL) with a stainless steel capillary and fittings.  
 
3. Results and discussion 
3.1 SEC-HPLC characteristics of HSA aggregates and polysorbates 
Figure 1 shows chromatograms of the HSA sample and the diluted polysorbate samples on the 
SEC-HPLC system without the precolumn at 215 nm. Spectrophotometric detection of proteins is 
frequently performed at 280 nm based on the absorption of tryptophan and aromatic amino acid residues. 
However, the photometric detection at 215 nm due to amide bonds is required for highly sensitive detection 
of protein targets at extremely low concentrations such as protein aggregates in protein-based 
pharmaceutical products. The main peak at a retention time of 17 min corresponds to HSA monomer, while 
the peaks at 15, 14.5, 14 min correspond to dimer, trimer and tetramer of HSA, respectively. Larger 
aggregates were eluted in the region of retention times from 11 to 14 min. In order to characterize the 
aggregation, the peak analysis of this region is very important. Unfortunately, PS80 and PS20 were eluted 
at retention times very close to that of as the aggregates of HSA. Although the molecular mass of PS80 and 
PS20 are smaller than that of HSA, the polysorbates were eluted at retention times earlier than the time 
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expected from the molecular mass. The reason may be that PS80 and PS20 can be formed in a micellar 
state in an aqueous solvent. This is a typical example of the interference from PS80 and PS20 in the 
SEC-HPLC quantification of aggregate contents as reported before [23].  
 We tried in this work to separate the polysorbate's peaks from the protein-derived ones by using a 
precolumn method because on-line analysis without any specific separation pretreatment of protein samples 
is convenient for chromatographic analysis of protein aggregates in protein-based pharmaceutical products.  
One of separation modes to be utilized for this purpose may be electrostatic interaction in anion or cation 
exchange. However, separation conditions for ion exchange chromatography have to be tuned for every 
protein, because the isoelectric points of proteins are different from each other. Another separation mode 
may be hydrophobic interaction in reversed-phase. One of weak points of this method is that the method 
requires organic solvents or ammonium sulfate in elution buffer. The situation may give some damages to 
proteins and may cause the dissociation of some non-covalent aggregates in reversed-phase 
chromatography and hydrophobic interaction chromatography. As a result, we have considered that some 
porosity silica gel with some hydrophobic characteristics may be effective to remove hydrophobic 
surfactants with relatively large molecular mass such as PS80 and PS20. In preliminary experiments we 
tried to use two kinds of anion exchange columns (GE Healthcare, Resource Q; and Tosoh, TSK-GEL 
DEAE 5PW), one anion/cation multi-mode column (Poly LC, PolyMix CW) and several reversed-phase 
columns (Tosoh, TSKgel guard column Super AW-L; Waters, -Bondasphere; and Agilent 
Technologies, Zorbax C8) as precolumns. However, these columns were not efficient for this purpose. We 
finally focused on Shodex MSpak GF-4A, which has been developed for column-switching method to 
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eliminate surfactant from surfactant-containing protein/peptide samples. Although MSpak GF-4A is mainly 
used for LC-MS because surfactants degrade LC-MS columns and decrease the reproducibility of LC-MS, 
we tried to use MSpak GF-4A as a precolumn connected to SEC column and to develop a new online 
SEC-HPLC method without column-switching system.  
 As expected, on the SEC-HPLC system without MSpak GF-4A, the peak area of PS80 and PS20 
increased in proportion to the injection amount of the polysorbates (Fig. 2A, B; black triangle). In contrast, 
when MSpak GF-4A was connected as a precolumn to the SEC-HPLC system, the PS80 peak was not 
detected at least up to 8-μg injection (Fig. 2A; gray triangle). Very small peak of PS80 was detected at 
20-μg injection and clearly detected at 40-μg injection with an area of 170 mAUsec. However, the peak 
area was much smaller than those observed in the separation without MSpak GF-4A. In the case of PS20, 
only very small peak was detected even at 20-μg and 40-μg injections when the MSpak GF-4A column was 
used (Fig. 2B; gray triangle). These results indicate that the MSpak GF-4A precolumn is very effective to 
trap PS80 and PS20 in the on-line mode. The limiting value of the trapping is about 10 g for PS80 and 20 
g for PS20. The difference of the trapping characteristics between PS20 and PS80 seem to be ascribed to 
multiplier effect of mixed characteristics of size exclusion phase and reversed-phase of the precolumn. 
Actually the difference cannot be simply explained from the hydrophobic properties of the polysorbates, 
and precolumns with the revered-phase characteristics alone did not work well to trap the polysorbates 
selectively. When 40 μg of PS80 was injected to the precolumn-SEC-HPLC system, the precolumn must be 
saturated with PS80. Therefore the succeeding injection of even small amounts of PS80 (for example 8 μg) 
could not be trapped. However, the PS80-suturated precolumn can still trap PS20. PS20 was scarcely 
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detected at 20-μg injection when the PS80-saturated precolumn was use. It is noteworthy that the detergent 
trapped in MSpak GF-4A is easily washed out with mixed aqueous mobile phase containing organic 
solvents such as acetonitrile (data not shown). Actually, the precolumn was cleaned with acetonitrile (30% 
v/v)-containing aqueous mobile phase after each analysis unless otherwise noted, when large amounts of 
polysorbates were injected. 
 
3.2 Effects of temperature on the one separation of protein aggregates on SEC-HPLC with MSpak GF-4A 
As described in Section 3.1, the MSpak GF-4A is very effective to trap polysorbates. However, it 
was found that the chromatograms of the HSA sample depend on the column temperature (Fig. 3A). Figure 
4A shows the dependence of the total peak area of the HSA aggregates on the column temperature. The 
peak area of the HSA aggregate increased with an increase in the column temperature from 5 C to 20 C 
and reached a constant value above 20 C at least up to 30 C (Fig. 4A, gray square), although the HSA 
monomer peak area was not affected by the column temperature (data not shown). In contrast, when only 
the SEC column was used without the precolumn, the total peak area of the aggregate and monomer was 
independent of the column temperature (data not shown). These results suggest that the HSA aggregates are 
specifically trapped on the MSpak GF-4A precolumn at lower temperatures predominantly by hydrophobic 
interaction. It has been reported that the high-order structure of protein aggregates usually differs from that 
of the monomer [24-26], although some protein aggregates seem to retain the high-order structure similar 
to that of monomer [26, 27]. In the case of HSA, the fluorescence spectral characteristics of the aggregates 
are different from those of the monomer (data not shown). This evidence suggests the change in the 
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high-order structure on the aggregation. Since the aggregates are susceptible to the adsorption on the 
precolumn at lower temperatures, the hydrophobic interaction between the aggregates and the stationary 
phase of the precolumn seems to be a major contribution to trap the aggregates on the precolumn. The 
hydrophobic interaction decreases with an increase in the column temperature, and the HSA aggregates can 
pass through the precolumn at column temperatures over 20 C. 
In contrast, the peak area of the heat-induced r-HuEPO aggregates decreased with an increase in 
the column temperature (Fig. 3B and Fig. 4B (gray diamond)) on the SEC-HPLC system with MSpak 
GF-4A. The limiting value of the peak was observed at column temperature lower than 10 C. The peak 
area of the r-HuEPO monomer was independent of the column temperature at least in the range from 5 to 
30 C as in the case of the HSA monomer. These phenomena may be caused by the high-order 
conformational change of the heat-induced r-HuEPO aggregates at increased column temperatures to 
induce the exposure of these hydrophobic surface.  
We also show another example of the column temperature dependence of protein aggregates. 
As shown in Figs. 3C and 4C, the peak shape and the area of the aggregate (dimer, peak 1) and monomer in 
the synagis injection are independent of the column temperature in the range from 5 C to 30 C. The 
synagis injection dimer seems to have characteristics similar to those of the monomer in view of the 
high-order structure and the surface property. The hydrophobic interaction between the synagis injection 
aggregate and the stationary phase of the MSpak GF-4A column is not so strong, as in the case of the 
monomer of the other proteins examined here. 
 Anyway, it is very important to control the column temperature to avoid the adsorption of protein 
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aggregetes in the MSpak GF-4A precolumn. The optimum temperature of the column must be selected for 
individual protein targets. 
 
3.3 HSA with and without PS80 analyzed by SEC-HPLC with and without MSpak GF-4A 
 In the region from 10 to 15 min, the peak shape of HSA with PS80 was significantly different 
from that of HSA without PS80 by analyzing SEC-HPLC without MSpak GF-4A (Fig 5-A). Not only 
aggregates but PS80 were eluted in the region. While, the peak shape of the HSA sample with PS80 on 
SEC-HPLC with MSpak GF-4A was almost the same as that of the HSA sample without PS80 on 
SEC-HPLC without MSpak GF-4A (Fig 5-B). PS80 was successfully trapped by MSpak GF-4A. The 
results clearly show that the connection of MSpak GF-4A to SEC column and the setting of proper column 
temperature (e.g., 25 C for HSA) allow to perform quantification of protein aggregate contents, because 
MSpak GF-4A can effectively eliminate of the interference from PS80.  
 
4. Conclusions 
We have proposed an improvement of the conventional SEC-HPLC method for analysis of 
protein aggregates in protein-based samples containing some detergents such as PS80 and PS20 by using 
MSpak GF-4A as a precolumn. The method performs an on-line analysis of protein aggregates. The mixed 
modes based on size exclusion phase and reversed-phase seem to effectively work to trap the detergents. 
However, some hydrophobic interaction between protein aggregates (especially with hydrophobic nature) 
and the stationary phase of the precolumn might cause to trap the protein aggregates in part. This work has 
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also revealed that such interference can be minimized by tuning the column temperature.  
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Figure 1. Chromatograms of the HSA sample (black solid line; 3 mg/mL10 L), diluted PS80 sample 
(gray solid line; 1 mg/mL40 L) and the diluted PS20 sample (gray dash line; 1 mg/mL40 L) on the 
SEC-HPLC system without the precolumn at 25 C (flow rate: 0.5 mL/min, UV detection: 215 nm). 
 
Figure 2. Effects of the precolumn MSpak GF-4A on the peak area of (A) PS80 and (B) PS20 detected on 
the SEC-HPLC system; (black triangle) without or (gray triangle) with the precolumn MSpak GF-4A. The 
error bars indicate the standard deviation (n = 3).  
 
Figure 3. Chromatograms of (A) the HSA sample (3 mg/mL10 μL), (B) heat-induced r-HuEPO sample (1 
mg/mL30 μL), (C) synagis injection sample (1 mg/mL20 μL) on the SEC-HPLC system with MSpak 
GF-4A at various column temperatures. Purple, blue, green, yellow, orange and red lines are each protein 
samples analyzed at 5, 10, 15, 20, 25 and 30C respectively. The peaks numbered as 1, 2, 3 and 4 of the 
HSA aggregates correspond to the dimer, trimer, tetramer and larger oligomer(s), respectively. Peak 1 of 
heat-induced r-HuEPO and synagis injection corresponds to the dimer. 
 
Figure 4. Effects of the column temperature on the total peak areas of the aggregates in (A) the HSA sample 
on the SEC-HPLC system with MSpak GF-4A (gray squares) and without MSpak GF-4A (black squares), 
(B) heat-induced r-HuEPO sample with MSpak GF-4A (gray diamonds) and without MSpak GF-4A (black 
diamonds) and (C) synagis injection sample with MSpak GF-4A (gray circles) and without MSpak GF-4A 
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(black circles). The error bars indicate the standard deviation (n = 3). 
 
Figure 5. (A) Chromatograms of HSA by SEC-HPLC without MSpak GF-4A; black line corresponds to the 
HSA sample (3 mg/mL10 μL) without PS80 and gray line is the HSA sample containing PS80 (HSA: 3 
mg/mL10 μL, PS80: 1 mg/mL10 μL). (B) Chromatograms of HSA; black line corresponds to the HSA 
sample (3 mg/mL10 μL) without PS80 on SEC-HPLC without MSpak GF-4A and gray line corresponds 
to the HSA sample containing PS80 (HSA: 3 mg/mL10 μL, PS80: 1 mg/mL 10 μL) by SEC-HPLC with 
MSpak GF-4A. 
Figure 1
Figure 2(A)
Figure 2(B) 
Figure 3(A) 
Figure 3(B) 
Figure 3(C)
Figure 4(A)
Figure 4(B) 
Figure 4(C) 
Figure 5(A)
 Figure 5(B)
